Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;36:449-453

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marro, M. L.
Right arrow Articles by Muro, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marro, M. L.
Right arrow Articles by Muro, A. F.
Related Collections
Right arrow Remodeling
Right arrow Apoptosis
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Hypertension - basic studies
Right arrow Myogenesis

(Hypertension. 2000;36:449.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Hypertension in ß-Adducin–Deficient Mice

Martín L. Marro1; Oscar U. Scremin1; Maria C. Jordan; Ly Huynh; Fabiola Porro; Kenneth P. Roos; Srecko Gajovic; Francisco E. Baralle; Andrés F. Muro

From the International Center for Genetic Engineering and Biotechnology, Trieste, Italy (M.L.M., F.P., S.G., F.E.B., A.F.M.); Department of Physiology, School of Medicine, University of California at Los Angeles (O.U.S., M.C.J., L.H., K.P.R.); Veterans Affairs GLA Healthcare System, Los Angeles, California (O.U.S., L.H.); and Department of Histology and Embryology, School of Medicine, University of Zagreb, Croatia (S.G.).

Correspondence to A.F. Muro, ICGEB, Padriciano, 99, 34012 Trieste, Italy. E-mail muro{at}icgeb.trieste.it

Abstract—Polymorphic variants of the cytoskeletal protein adducin have been associated with hypertension in humans and rats. However, the direct role of this protein in modulating arterial blood pressure has never been demonstrated. To assess the effect of ß-adducin on blood pressure, a ß-adducin–deficient mouse strain (-/-) was studied and compared with wild-type controls (+/+). Aortic blood pressure was measured in nonanesthetized, freely moving animals with the use of telemetry implants. It is important to note that these mice have at least 98% of C57Bl/6 genetic background, with the only difference from wild-type animals being the ß-adducin mutation. We found statistically significant higher levels of systolic blood pressure (mm Hg) (mean±SE values: -/-: 126.94±1.14, n=5; +/+: 108.06±2.34, n=6; P<=0.0001), diastolic blood pressure (-/-: 83.54±1.07; +/+: 74.87±2.23; P<=0.005), and pulse blood pressure (-/-: 43.32±1.10; +/+: 33.19±1.96; P<=0.001) in ß-adducin–deficient mice. Western blot analysis showed that as a result of the introduced genetic modification, ß-adducin was not present in heart protein extracts from -/- mice. Consequently, this deficiency produced a sharp decrease of {alpha}-adducin and a lesser reduction in {gamma}-adducin levels. However, we found neither cardiac remodeling nor modification of the heart function in these animals. This is the first report showing direct evidence that hypertension is triggered by a mutation in the adducin gene family.


Key Words: hypertension, genetic • adducin • mice, knockout • echocardiography • cytoskeleton • telemetry • electrocardiography




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
N. Kato, T. Miyata, Y. Tabara, T. Katsuya, K. Yanai, H. Hanada, K. Kamide, J. Nakura, K. Kohara, F. Takeuchi, et al.
High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project
Hum. Mol. Genet., February 14, 2008; 17(4): 617 - 627.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. J. Mullins, M. A. Bailey, and J. J. Mullins
Hypertension, Kidney, and Transgenics: A Fresh Perspective
Physiol Rev, April 1, 2006; 86(2): 709 - 746.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Correction
J. Neurosci., April 6, 2005; 25(14): .
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor
Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases
Physiol Rev, April 1, 2005; 85(2): 679 - 715.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Yang, P. Y. Reaves, M. J. Katovich, and M. K. Raizada
Decrease in Hypothalamic Gamma Adducin in Rat Models of Hypertension
Hypertension, February 1, 2004; 43(2): 324 - 328.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Yang, S. C. Francis, K. Sellers, M. DeBarros, C. Sun, C. Sumners, C. M. Ferrario, M. J. Katovich, A. F. Muro, and M. K. Raizada
Hypertension-Linked Decrease in the Expression of Brain {gamma}-Adducin
Circ. Res., October 4, 2002; 91(7): 633 - 639.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. J. A. Janssen and J. F. M. Smits
Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. P. Holschneider, O. U. Scremin, D. R. Chialvo, K. Chen, and J. C. Shih
Heart rate dynamics in monoamine oxidase-A- and -B-deficient mice
Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1751 - H1759.
[Abstract] [Full Text] [PDF]